Invectys SA:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Invectys SA - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11252
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:18
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Invectys SA (Invectys) is a biopharmaceutical company that develops immunotherapy to treat cancer. The company provides product pipeline such as INVAC-1, a DNA vaccine targeting Telomerase; Universal Cancer Peptide vaccine UCPVax. It offers products such as a human telomerase peptide-based vaccine; INMAB-1, a monoclonal antibody; and TelVet, a dog telomerase DNA-based anti-cancer vaccine and similar to INVAC-1. Invectys TelVet is developed for the treatment of pet cancers such as dog cancers. The company’s technology restores and mobilizes the anti-tumor ability of the immune system of cancer patients. Invectys is headquartered in Paris, France.

Invectys SA – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Invectys SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Invectys SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Invectys SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Invectys SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Invectys SA, Medical Devices Deals, 2012 to YTD 2018 9
Invectys SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Invectys SA, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Invectys Raises USD17.10 Million in Series A Financing 11
Invectys Raises USD5 Million in Venture Financing 12
Invectys Raises USD7.6 Million in Venture Financing 13
Invectys Raises USD2 Million in Venture Financing 14
Invectys SA – Key Competitors 15
Invectys SA – Key Employees 16
Invectys SA – Locations And Subsidiaries 17
Head Office 17
Appendix 18
Methodology 18
About GlobalData 18
Contact Us 18
Disclaimer 18

List of Tables
Invectys SA, Pharmaceuticals & Healthcare, Key Facts 2
Invectys SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Invectys SA, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Invectys SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Invectys SA, Deals By Therapy Area, 2012 to YTD 2018 8
Invectys SA, Medical Devices Deals, 2012 to YTD 2018 9
Invectys SA, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Invectys Raises USD17.10 Million in Series A Financing 11
Invectys Raises USD5 Million in Venture Financing 12
Invectys Raises USD7.6 Million in Venture Financing 13
Invectys Raises USD2 Million in Venture Financing 14
Invectys SA, Key Competitors 15
Invectys SA, Key Employees 16

List of Figures
Invectys SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Invectys SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Invectys SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Invectys SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Invectys SA, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Invectys SA, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Invectys SA, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Invectys SA, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Invectys SA, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[Invectys SA:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • The Goldman Sachs Group Inc (GS):企業の財務・戦略的SWOT分析
    The Goldman Sachs Group Inc (GS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Heliatek GmbH-エネルギー分野:企業M&A・提携分析
    Summary Heliatek GmbH (Heliatek) is a solar energy company that manufactures and constructs organic photovoltaics. The company manufactures modules on flexible substrates utilizing a roll-to-roll production process. Its products include OPV oligomers, OPV polymers, and OPV dye-sensitized solar cells …
  • Kohl’s Corporation (KSS):企業の財務・戦略的SWOT分析
    Kohl's Corporation (KSS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Vesteda Group:企業の戦略・SWOT・財務情報
    Vesteda Group - Strategy, SWOT and Corporate Finance Report Summary Vesteda Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Antabio SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Antabio SAS (Antabio) is a biopharmaceutical company that develops novel antibacterials targeting drug-resistant pathogens. The company’s pipeline products comprise Metallo Beta-Lactamases inhibitors, Pseudomonas Biofilms inhibitors and others. It uses in vitro technologies and bacterial dis …
  • SK Biopharmaceuticals Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary SK Biopharmaceuticals Co Ltd (SK Biopharmaceuticals), a subsidiary of SK Holdings Co Ltd is a developer of drug candidates. The company develops and markets innovative drugs for the treatment of central nervous system. It offers plumiaz, SKL-N05 and JZP-110; YKP3089, relenopride, SKL-PD, SKL …
  • Linear Technology Corporation (LLTC):企業の戦略的SWOT分析
    Linear Technology Corporation (LLTC) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and majo …
  • Mechanical Technology Inc (MKTY):企業の財務・戦略的SWOT分析
    Summary Mechanical Technology Inc (MTI) is an electronic equipment company that designs, manufactures, and sells test and measurement instruments and systems. The company offers tools, systems and solutions for markets and applications that require precise measurements and control of products, proce …
  • Flipkart Internet Private Limited:企業のM&A・事業提携・投資動向
    Flipkart Internet Private Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Flipkart Internet Private Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Select Medical Holdings Corp (SEM):企業の財務・戦略的SWOT分析
    Summary Select Medical Holdings Corp (SMHC) is a healthcare service provider that offers outpatient rehabilitation services. The center provides long-term acute care services such as cardiac services, infectious disease treatment, medically complex treatment, neuro or post-trauma, pulmonary or venti …
  • Community Health Systems Inc (CYH):製薬・医療:M&Aディール及び事業提携情報
    Summary Community Health Systems Inc. (CHS) is an operator of general acute care hospitals and outpatient facilities in communities. The company’s services include general acute care services, emergency room services, general and specialty surgery, critical care, internal medicine, obstetrics and di …
  • LivaNova PLC (LIVN):企業の財務・戦略的SWOT分析
    LivaNova PLC (LIVN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • EpiVax Inc:企業の戦略的SWOT分析
    EpiVax Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. T …
  • Invuity Inc (IVTY)-医療機器分野:企業M&A・提携分析
    Summary Invuity Inc (Invuity) is a medical technology company that offers visualization products for the less invasive surgical procedures. The company offers handhelds, retractors and drop-ins. Its handhelds products include saber frazier and saber yankauer. Invuity offers retractors such as breite …
  • American Overseas Group Limited
    American Overseas Group Limited - Strategy, SWOT and Corporate Finance Report Summary American Overseas Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Arcelik A.S. (ARCLK):企業の財務・戦略的SWOT分析
    Arcelik A.S. (ARCLK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • International Speedway Corporation:企業の戦略・SWOT・財務情報
    International Speedway Corporation - Strategy, SWOT and Corporate Finance Report Summary International Speedway Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • NanoRepro AG (NN6):医療機器:M&Aディール及び事業提携情報
    Summary NanoRepro AG (NanoRepro) is a manufacturer of fast-diagnostics and nutritional food supplements for home and clinical use. The company offers wide range of rapid diagnostic tests products in the areas of family planning, disease detection (preventive healthcare), food intolerances, allergies …
  • Middle East Airlines:企業の戦略・SWOT・財務情報
    Middle East Airlines - Strategy, SWOT and Corporate Finance Report Summary Middle East Airlines - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Consort Medical plc (CSRT):製薬・医療:M&Aディール及び事業提携情報
    Summary Consort Medical plc (Consort Medical) is a contract development and manufacturing organization (CDMO) with focus on medical device technologies for drug delivery. It develops, manufactures and markets high volume disposable medical devices for drug delivery and point-of-care (POC) diagnostic …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆